Skip to main content
Fig. 3 | BMC Infectious Diseases

Fig. 3

From: Antimicrobial susceptibility testing in predicting the presence of carbapenemase genes in Enterobacteriaceae in South Africa

Fig. 3

Genotype information in carbapenemase producing isolates over the 3 year period. 2012 – NDM n = 25, 71 %; KPC n = 2, 6 %; OXA-48 n = 4, 11 %; IMP n = 2, 6 %; VIM n = 2, 6 %; GES n = 0. 2013 – NDM n = 99, 49 %; KPC n = 6, 3 %; OXA-48 n = 38, 19 %; IMP n = 32, 16 %; VIM n = 18, 9 %; GES n = 9, 4 %. 2014 – NDM n = 162, 50 %; KPC n = 3, 1 %; OXA-48 n = 104, 32 %;IMP n = 1, 0.3 %;VIM n = 47, 14 %;GES n = 9, 3 %. 2015 – NDM n = 183, 66 %; KPC n = 0; OXA-48 n = 73, 26 %; IMP n = 0; VIM n = 22, 8 %; GES n = 0

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us